{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:11:05Z","timestamp":1785431465543,"version":"3.56.0"},"reference-count":29,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300543"],"award-info":[{"award-number":["82300543"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82300543"],"award-info":[{"award-number":["82300543"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Background: Postoperative antiplatelet selection after coronary artery bypass grafting (CABG) in adults aged \u226570 years requires balancing ischemic protection against bleeding risk. Methods: We conducted a single-center retrospective cohort study of adults aged \u226570 years who underwent isolated CABG for unstable angina between 2017 and 2021. The exposure was the initial discharge antiplatelet pathway: aspirin 100 mg once daily or indobufen 100 mg twice daily as the cyclooxygenase-inhibitor component, combined with a P2Y12 inhibitor during the first postoperative year and followed by the same cyclooxygenase inhibitor during the second year. Propensity scores were estimated using multivariable logistic regression with 16 prespecified baseline covariates, and stabilized inverse probability of treatment weighting (IPTW) was applied. The primary analyses used IPTW-weighted Cox models. Results: Among 336 screened patients, 79 were included in the final analytic cohort (aspirin-based pathway, n = 49; indobufen-based pathway, n = 30). After weighting, measured covariate balance improved, although residual imbalance remained for prior myocardial infarction and prior percutaneous coronary intervention. At 24 months, no statistically significant association was observed between pathway and MACCE (HR 0.858, 95% CI 0.257\u20132.866; p = 0.803), BARC grade \u22652 bleeding (HR 0.359, 95% CI 0.093\u20131.385; p = 0.137), or NACE (HR 0.526, 95% CI 0.204\u20131.360; p = 0.185). Graft surveillance was evaluable in 77\/79 patients at 1 year and 71\/79 at 2 years and was analyzed descriptively. Conclusions: In this real-world cohort of older patients undergoing CABG for unstable angina, an initial indobufen-based discharge pathway was not statistically significantly associated with 24-month MACCE, BARC grade \u22652 bleeding, or NACE compared with an aspirin-based pathway after stabilized IPTW. These findings add exploratory CABG-specific data on indobufen in older patients and should be confirmed in larger prospective studies.<\/jats:p>","DOI":"10.3390\/jcdd13080356","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:16:52Z","timestamp":1785313012000},"page":"356","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Indobufen Versus Aspirin After CABG for Unstable Angina in Patients Aged 70 Years and Older"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0015-6721","authenticated-orcid":false,"given":"Ben","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital Xiamen Branch, Fudan University, Xiamen 361006, China"},{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou 350001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9417-3245","authenticated-orcid":false,"given":"Libin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[{"name":"Shengli Clinical Medical College, Fujian Medical University, Fuzhou 350001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3687-5306","authenticated-orcid":false,"given":"Quanlin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital Xiamen Branch, Fudan University, Xiamen 361006, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: A report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.117.027597","article-title":"Mechanisms, Consequences, and Prevention of Coronary Graft Failure","volume":"136","author":"Gaudino","year":"2017","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.120.052163","article-title":"Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies","volume":"144","author":"Xenogiannis","year":"2021","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/icvts\/ivaa115","article-title":"Antiplatelet Therapy and Coronary Artery Bypass Grafting: A Systematic Review and Network Meta-Analysis","volume":"31","author":"Gupta","year":"2020","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, and EACTS Scientific Document Group (2024). 2024 EACTS Guidelines on Perioperative Medica-tion in Adult Cardiac Surgery. Eur. J. Cardio-Thorac. Surg., 67, ezae355.","DOI":"10.1093\/ejcts\/ezaf169"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the Management of Acute Coronary Syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jama.2022.11966","article-title":"Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis","volume":"328","author":"Sandner","year":"2022","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e075707","DOI":"10.1136\/bmj-2023-075707","article-title":"Antiplatelet Therapy after Coronary Artery Bypass Surgery: Five-Year Follow-up of Randomised DACAB Trial","volume":"385","author":"Zhu","year":"2024","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0735-1097(99)00606-3","article-title":"Outcomes of Cardiac Surgery in Patients Age \u226580 Years: Results from the National Cardiovascular Network","volume":"35","author":"Alexander","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/j.jvca.2007.08.007","article-title":"Results and Predictors of Early and Late Outcomes of Coronary Artery Bypass Graft Surgery in Octogenarians","volume":"21","author":"Filsoufi","year":"2007","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ncpcardio1348","article-title":"Comparison of Coronary Revascularization Procedures in Octogenarians: A Systematic Review and Meta-Analysis","volume":"5","author":"McKellar","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and Validation of the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) Score: A Pooled Analysis of Individual-Patient Datasets from Clinical Trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2013.09.070","article-title":"Frailty Assessment in the Cardiovascular Care of Older Adults","volume":"63","author":"Afilalo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(20)30325-1","article-title":"Clopidogrel versus Ticagrelor or Prasugrel in Patients Aged 70 Years or Older with Non-ST-Elevation Acute Coronary Syndrome (POPular AGE): A Randomised, Open-Label, Non-Inferiority Trial","volume":"395","author":"Gimbel","year":"2020","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00002512-200118050-00007","article-title":"Indobufen: An Updated Review of Its Use in the Management of Atherothrombosis","volume":"18","author":"Bhana","year":"2001","journal-title":"Drugs Aging"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liu, J., Sun, P., and Qi, X. (2023). Reversible and Non-Competitive Inhibition of Cyclooxygenase by Indobufen for Efficient Antiplatelet Action and Relief of Gastrointestinal Irritation. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082135"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107465","DOI":"10.1016\/j.vph.2025.107465","article-title":"Indobufen versus Aspirin in Patients with Indication for Antiplatelet Therapy: A Systematic Review and Meta-Analysis","volume":"158","author":"Cavalcante","year":"2025","journal-title":"Vasc. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/FJC.0000000000001681","article-title":"Role of Indobufen in Coronary Artery Disease: The Story of a Neglected Drug. A Systematic Review","volume":"85","author":"Pepe","year":"2025","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/CIRCULATIONAHA.122.062762","article-title":"Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point-Blinded, Noninferiority Trial","volume":"147","author":"Wu","year":"2023","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dai, C., Liu, M., Yang, Z., Li, Y., Zhou, Y., Lu, D., Xia, Y., Chen, A., Li, C., and Lu, H. (2024). Real-World Performance of Indobufen versus Aspirin after Percutaneous Coronary Intervention: Insights from the ASPIRATION Registry. BMC Med., 22.","DOI":"10.1186\/s12916-024-03374-3"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dai, W., Mu, G., Ren, J., Hu, S., Guo, R., Gu, T.S., Che, J., Ma, X., Liu, T., and Wu, X. (2025). Indobufen versus Aspirin after Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-04843-0"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00019501-199809040-00007","article-title":"Indobufen Compared with Aspirin and Dipyridamole on Graft Patency after Coronary Artery Bypass Surgery: Results of a Combined Analysis","volume":"9","author":"Cataldo","year":"1998","journal-title":"Coron. Artery Dis."},{"key":"ref_25","first-page":"466","article-title":"A Randomized Controlled Trial of Indobufen versus Aspirin in the Prevention of Bridging Restenosis after Coronary Artery Bypass Grafting","volume":"50","author":"Bai","year":"2022","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ren, Y., Zhu, Y., Yan, Q., Jin, H., and Luo, H. (2024). Multicenter Retrospective Cohort Study Demonstrates Superior Safety Profile of Indobufen over Aspirin for Post-CABG Antiplatelet Therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1474150"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"47047","DOI":"10.31083\/HSF47047","article-title":"The Effect of Dual Antiplatelet Thera-py on Bleeding, Transfusion, and Long-Term Outcomes After Transcatheter Aortic Valve Replacement","volume":"28","author":"Row","year":"2025","journal-title":"Heart Surg. Forum"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wawruch, M., Murin, J., Tesar, T., Paduchova, M., Petrova, M., Celovska, D., Matalova, P., Havelkova, B., Trnka, M., and Aarnio, E. (2021). Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121800"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/356\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T08:49:46Z","timestamp":1785314986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/8\/356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcdd13080356"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13080356","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}